Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH).
Gastroenterol Hepatol
; 45(9): 724-734, 2022 Nov.
Article
in En, Es
| MEDLINE
| ID: mdl-35248669
ABSTRACT
This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology, with a particular focus on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis and end-stage hepatocellular carcinoma (HCC).
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Non-alcoholic Fatty Liver Disease
/
Gastroenterology
/
Liver Neoplasms
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
/
Es
Journal:
Gastroenterol Hepatol
Year:
2022
Type:
Article
Affiliation country:
Spain